- Citations, last 5 years
- 95
- Works, last 5 years
- 10
- h-index
- 25
- Scientists listed
- 4
- Grants since 2016
- 12
Grants received
2023–2024 · research · Global Health
Co-Diagnostics, Inc. - to develop an instrument and disposable cartridge for the detection of Mycobacterium tuberculosis (MTB) at low cost for deployment into low- and m...
MBio Diagnostics (United States) · funded by Bill and Melinda Gates Foundation
2023–2026 · research · Global Health
Co-Diagnostics, Inc. - To make affordable and accessible point-of-care diagnostics for Tuberculosis that will help eliminate the disease worldwide.
MBio Diagnostics (United States) · funded by Bill and Melinda Gates Foundation
2023–2024 · research · Global Health
Co-Diagnostics, Inc. - to develop an instrument and disposable cartridge for the detection of human papilloma virus (HPV) at low cost for deployment into low- and middle-...
MBio Diagnostics (United States) · funded by Bill and Melinda Gates Foundation
2022–2024 · research · R41
Point-of-care microdevices for simultaneous detection of multiple pertussis-like respiratory diseases from Bordetella species
Xiujun Li · MBio Diagnostics (United States) · funded by National Institutes of Health
2022–2026 · research · R41
Point-of-care microdevices for simultaneous detection of multiple pertussis-like respiratory diseases from Bordetella species
Xiujun Li · MBio Diagnostics (United States) · funded by National Institutes of Health
2020–2025 · research · R44
Rapid phage-amplified immunoassay for phenotypic UTI diagnosis and antimicrobial susceptibility testing
Christopher R Cox · MBio Diagnostics (United States) · funded by National Institutes of Health
2020–2024 · research · R44
Rapid phage-amplified immunoassay for phenotypic UTI diagnosis and antimicrobial susceptibility testing
Christopher R Cox · MBio Diagnostics (United States) · funded by National Institutes of Health
2020 · grant · Standard Grant
SBIR Phase I: Development and assessment of a diagnostic platform for rapid identification of COVID-19 patients without using custom reagents
Rajesh Krishnamurthy · MBio Diagnostics (United States) · funded by National Science Foundation
2019–2021 · research · R43
An Integrated Genetic-Epigenetic Tool for the Prediction of CHD Incidence in African-Americans
Meeshanthini Vijayendran Dogan · MBio Diagnostics (United States) · funded by National Institutes of Health
2017–2021 · research · R44
Point-of-Care Prognostic Tool for Sepsis
Michael J Lochhead · MBio Diagnostics (United States) · funded by National Institutes of Health
2017–2022 · research · R44
Point-of-Care Prognostic Tool for Sepsis
Michael J Lochhead · MBio Diagnostics (United States) · funded by National Institutes of Health
2017–2019 · research · R43
Point-of-Care Prognostic Tool for Sepsis
Michael J Lochhead · MBio Diagnostics (United States) · funded by National Institutes of Health
